Therapeutics

Funds will support clinical/regulatory development of the Vensica urology treatment platformPublished: Nov. 1, 2021 at 6:00 AM EDT|Updated: 4 hours...

Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design

Melinda D. Loyola February 5, 2021

The MarketWatch News Department was not involved in the creation of this content. Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a...

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Therapeutics

Vensica Therapeutics Closes $16 Million Investment Round

Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design

Most Apple iPhones in the US are sold through carriers

Hello, ChatGPT—Please Explain Yourself! – IEEE Spectrum

gRPC Remote Procedure Call (with Protobuf) – Grape Up

How Cognitive Science And Artificial Intelligence Are Transforming Global Industries?

Daily Authority: 🙏 Pixel Fold renders

Vensica Therapeutics Closes $16 Million Investment Round

Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design

Related Article

Most Apple iPhones in the US are sold through carriers

Hello, ChatGPT—Please Explain Yourself! – IEEE Spectrum

gRPC Remote Procedure Call (with Protobuf) – Grape Up

How Cognitive Science And Artificial Intelligence Are Transforming Global Industries?

Daily Authority: 🙏 Pixel Fold renders